Chempartner Pharmatech Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 554.52 million compared to CNY 679.4 million a year ago. Revenue was CNY 557.45 million compared to CNY 686.9 million a year ago.

Net loss was CNY 21.78 million compared to net income of CNY 956.58 million a year ago. Basic loss per share from continuing operations was CNY 0.04 compared to basic earnings per share from continuing operations of CNY 1.92 a year ago. Diluted loss per share from continuing operations was CNY 0.04 compared to diluted earnings per share from continuing operations of CNY 1.92 a year ago.